-
Cotation en bourse
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLire la suiteWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Trading
Where European Government Bonds meet the futureFixed Income derivativesLire la suiteTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLire la suiteEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLire la suiteEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lire la suiteThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Réglementation
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lire la suiteShaping capital markets for future generations
-
Cotation en bourse
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLire la suiteWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Trading
Where European Government Bonds meet the futureFixed Income derivativesLire la suiteTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLire la suiteEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLire la suiteEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lire la suiteThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Réglementation
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lire la suiteShaping capital markets for future generations
- Accueil
- About
- Media centre
- Bell Ceremony Archive
- Introduction en bourse de la biotech arGEN-X sur EnterNext à Bruxelles
Introduction en bourse de la biotech arGEN-X sur EnterNext à Bruxelles
Depuis le 10 juillet 2014, l’action arGEN-X est cotée sur EnterNext Bruxelles. Pour célébrer cet événement, Tim Van Hauwermeiren, CEO de arGEN-X a ouvert les marchés européens en sonnant la cloche. Hans de Haard, co-fondateur de arGEN-X a eu l'honneur d'inscrire le premier cours sur le tableau noir. Le prix de référence de la biotech a été fixé à 8.50 euros.
arGEN-X est spécialisé dans la recherche et le développement d’anticorps monoclonaux humains destinés au traitement des maladies oncologiques, auto-immunes et inflammatoires.
A fin 2013, la société disposait d’un portefeuille de 2 produits en phase I de développement clinique et de 3 produits en phase de développement préclinique.
Le symbole de cotation est : ARGX.
Pour en savoir plus, cliquez sur www.argen-x.com